Physician

Jinu Jacob John, M.D.

According to 2025 Medicare claims, Jinu John, M.D. (NPI: 1467682369) practices cardiology in the Manchester-Nashua, NH market, with the plurality of this provider's patient population coming from Hillsborough, NH. This provider's primary affiliated billing organization is CARDIOVASCULAR SPECIALISTS OF NEW ENGLAND, LLC (NPI: 1992563589; TIN: 991635988) and primary practice location at 03053-3417. John is affiliated with the MaineHealth Accountable Care Organization (ACO ID: A1290), Aledade 205 New England MSSP Enhanced (ACO ID: A5370), Aledade 201 National MSSP (ACO ID: A5522), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

John's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,328 traditional Medicare patients, billed 4,810 HCPCS/CPT codes, and received $241,805 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,703 prescription claims across 330 beneficiaries totaling $512,809 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 33 records totaling $3,202. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $90,129 and ending at $241,805. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $22,295 to $512,809. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	1,663	2,305	$90,129
2018	3,968	6,769	$205,363
2019	3,601	5,979	$178,812
2020	3,546	5,510	$141,392
2021	3,713	5,957	$172,042
2022	3,397	6,182	$192,176
2023	2,719	5,409	$181,869
2024	2,328	4,810	$241,805

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	47	138	$22,295
2018	129	934	$154,579
2019	159	987	$160,981
2020	176	1,152	$252,674
2021	197	1,002	$234,049
2022	238	1,243	$317,975
2023	293	1,525	$451,258
2024	330	1,703	$512,809

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	254	309	$85
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	217	313	$21
93248	Heart rhythm review and interpretation of continous external ekg over 8-15 days	247	247	$19
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	138	156	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	1,598	2,208	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	355	20,258	$393,659
Xarelto	Rivaroxaban	69	3,780	$68,888
Dofetilide	Dofetilide	33	1,590	$6,577
Mexiletine Hcl	Mexiletine Hcl	54	2,770	$6,529
Metoprolol Succinate	Metoprolol Succinate	348	22,165	$5,574

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	33	$3,202	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jinu Jacob John, M.D.?

Tedicare shows public-source Medicare data for Jinu Jacob John, M.D. (NPI 1467682369), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jinu Jacob John, M.D. have ACO affiliation data?

Jinu Jacob John, M.D. is shown with ACO affiliation data for MaineHealth Accountable Care Organization (MSSP, ACO ID A1290), Aledade 205 New England MSSP Enhanced (MSSP, ACO ID A5370), Aledade 201 National MSSP (MSSP, ACO ID A5522), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Jinu Jacob John, M.D.?

Jinu Jacob John, M.D. is linked to CARDIOVASCULAR SPECIALISTS OF NEW ENGLAND, LLC (billing NPI 1992563589) in the available physician profile data.

Does Jinu Jacob John, M.D. have Open Payments data?

Jinu Jacob John, M.D. has 33 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.